Meagan Toothman, 24, was confirmed as the seventh person to die from the Aug. 13 stage collapse, according to a statement from the Marion County coroner's office released Monday night by the Indiana State Police.
Leadership in wake of State Fair stage collapse compared to aftermath of Sept. 11 terrorist attacks, Minnesota bridge disaster.
Indeed, an astute governor who wants to push the boundaries of executive power can simply do so when legislators are looking the other way. While they are literally out of town.
WellPoint lobbied on issues tied to the overhaul's implementation and regulations for accountable care organizations, which are networks of hospitals, doctors, rehabilitation centers and other providers that coordinate a patient's care.
Two years into the economic recovery, bright spots in the Indiana job market are still hard to find. The insurance industry is one of the few glimmers of light on Indiana’s horizon. Others include engine makers, nursing homes and temp agencies.
Fishers investment manager Keenan Hauke suffered massive losses in his hedge fund seven years ago. Then, rather than fess up, he generated fake account statements for clients that showed money they didn’t really have and returns they hadn’t earned, state investigators allege.
With reluctance, Mike Alley, a veteran Indianapolis banker, joined the board of Evansville-based Integra Bank in April 2009. A month later, he found himself CEO—the beginning of a 26-month odyssey that ended July 29 with banking regulators seizing and shutting down the 160-year-old institution.
An innovative private financing deal struck last year to expand Denver’s rail transit system could be used to expedite construction of the first line in central Indiana.
Owners and operators of Indianapolis meeting venues are in the midst of a high-stakes game of musical chairs. The winners will land the biggest parties and events affiliated with Super Bowl XLVI.
The Central Indiana Community Foundation’s State Fair Remembrance Fund is on pace to raise hundreds of thousands of dollars for victims of the stage collapse.
Auditors are reviewing whether Ener1 Inc., which has hundreds of workers in the Indianapolis area, has enough cash to continue operations.
If Peyton Manning isn't ready to start the regular season, Brett Favre would be a guy who could keep the team's Super Bowl hopes alive this year.
Remember when physicians were highly suspicious of retail clinics in drugstores' stealing business from them? Well, now that docs are employed by hospitals, the clinics are being embraced. Indiana University Health announced last week that its physicians will serve as medical directors for 19 MinuteClinic locations, including 17 in the Indianapolis area, one in Bloomington and one in West Lafayette. The clinics are in CVS drugstores, as the company is a subsidiary of Rhode Island-based CVS Caremark Corp. Signs at the clinics will indicate the affiliation with IU Health. The organizations are linking their electronic medical record systems so that, with patient permission, records could be transferred easily from MinuteClinic to an IU Health physician, especially for patients needing more care than MinuteClinic can provide. However, MinuteClinic nurse practitioners will also send patient records to non-IU Health physicians if the patient wishes. The IU Health deal is the 11th hospital partnership signed by MinuteClinic across the country.
Eli Lilly and Co. could get an earlier-than-expected ruling from the U.S. Food and Drug Administration on its once-weekly version of Byetta. The FDA said it would render a decision on the new diabetes drug, called Bydureon, by Jan. 28, Lilly announced last week along with its partners, California-based Amylin Pharmaceuticals Inc. and Massachusetts-based Alkermes Inc. Bydureon would be a once-weekly injection of exenatide, the same compound in Byetta, which currently requires twice-daily injections. Byetta has proved effective at controlling blood sugar and even helping some patients lose weight. But concerns about it include causing pancreas problems and then competition from a similar once-daily drug called Victoza, launched by Denmark-based Novo Nordisk A/S. Lilly expected to receive approval for Bydureon in 2010, but the FDA required another study to test its effects on patients’ heart rhythms. When the new requirement was announced in October, Lilly said it expected approval of Bydureon to be delayed until mid-2012. Worldwide Byetta sales last year totaled $710 million.
A $10 million research endowment at the Eugene and Marilyn Glick Eye Institute has attracted seven new researchers to the Indiana University School of Medicine’s Ophthalmology Department. The department will move this month to a new building at 1160 W. Michigan St. The Glicks pledged a total of $30 million to the medical school—including $20 million that went toward the 80,000-square-foot building, which will house clinical research space, a full-service optical shop and the ophthalmology outpatient clinic. The clinic, which is moving from University Hospital, will double in size. The local philanthropists hoped their gift would vault IU into the top 10 for research and prevention of eye disease.
Strong winds caused the stage rigging for an outdoor concert to collapse, trapping fans.
Revised Insurance Department data show the Indianapolis-based carrier claims about 60 percent of the individual health insurance market in Indiana, down from a previously reported 65 percent.
Indianapolis’ second-largest law firm could complete a deal with Minneapolis-based Faegre & Benson LLP in October. A need to get larger and to establish a regional presence is fueling the talks.
While we at the Indianapolis Rowing Center applaud Bill Benner’s [July 23 column] call for attention to the crumbling infrastructure of our city’s amateur sports facilities, we’d like to add one bright spot—the rowing center.
A proposal in front of a City-County Council committee would require ticket brokers to purchase an annual license to sell tickets within one mile of an event venue.
A WXIN-TV Channel 59 report suggests the city of Carmel hired private investigators to tail Steven Libman, who resigned abruptly last month as CEO of the Center for the Performing Arts in Carmel.
